Skip to main content
Top

2019 | OriginalPaper | Chapter

Precision Medicine: A Personalized Treatment from Your Gene

Authors : P. K. Balasubramani, K. Preetha, M. Aswanth Harish

Published in: Proceedings of the International Conference on Nanomedicine (ICON-2019)

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Poor healthcare linked to 5 million annual death worldwide. Health is increasingly shaped by ageing populations, urbanization and globalization of unhealthy lifestyles, resulting in a transition in the burden of health care towards non communicable diseases, mental health and injuries. Many of these conditions are chronic, requiring long-term care, with patients commonly suffering from multi-morbidities, all of which adds to escalating health care costs. Precision medicine (PM) is a new approach to health care that matches individual patients with targeted treatments that work best for each them. PM is still in its infancy, but holds so much promise for the healthcare industry which considers genetic variations, environment and lifestyle. There would be global shift in the treatment modalities where people are moving towards pharmacogenomics which takes into consideration of the individual drug response to how body metabolize it helping in catering the patients with minimal Adverse Drug Reaction (ADR). Another field which is showing promise in the healthcare industry is wearable bio-services for better health and disease management. PM has roadblocks to clear before it hits the market clinician acceptability, pharma industry to cater drug to small population, developing diagnostic tests with sufficient sensitivity and specificity and having string regulatory mechanism to ensure clinical validity to the tests.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Kalaitzopoulos, D.: The potential of precision medicine. New Horizons Transl. Med. 3, 63–65 (2016) Kalaitzopoulos, D.: The potential of precision medicine. New Horizons Transl. Med. 3, 63–65 (2016)
2.
go back to reference Kwon, H., Jung, E.-Y.: The impact of policy on the growth of precision medicine. Healthy Policy Technol. 7, 347–357 (2018)CrossRef Kwon, H., Jung, E.-Y.: The impact of policy on the growth of precision medicine. Healthy Policy Technol. 7, 347–357 (2018)CrossRef
4.
go back to reference Roukos, D.H.: Clinical cancer genome and precision medicine. Ann SurgOncol. 19(12), 3646–3650 (2012) Roukos, D.H.: Clinical cancer genome and precision medicine. Ann SurgOncol. 19(12), 3646–3650 (2012)
6.
go back to reference Mesko, B.: The role of artificial intelligence in precision medicine. Expert Rev. Precis. Med. Drug Dev. 2(5), 239–241 (2017)CrossRef Mesko, B.: The role of artificial intelligence in precision medicine. Expert Rev. Precis. Med. Drug Dev. 2(5), 239–241 (2017)CrossRef
7.
go back to reference Knowles, L.: Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. J. Law Biosci. 4, 453–506 (2017)CrossRef Knowles, L.: Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. J. Law Biosci. 4, 453–506 (2017)CrossRef
8.
go back to reference Awwalu, J., Garba, A.G., Ghazvini, A., Atuah, R.: Artificial intelligence in personalized medicine application of ai algorithms in solving personalized medicine problems. Int. J. Comput. Theory Eng. 7(6), 439–443 (2015)CrossRef Awwalu, J., Garba, A.G., Ghazvini, A., Atuah, R.: Artificial intelligence in personalized medicine application of ai algorithms in solving personalized medicine problems. Int. J. Comput. Theory Eng. 7(6), 439–443 (2015)CrossRef
9.
go back to reference Williams, A.M., Liu, Y., Regner, K.R., Jotterand, F., Liu, P., Liang, M.: Artificial intelligence, physiological genomics, and precision medicine. Physiol. Genom. 50(4), 237–243 (2018)CrossRef Williams, A.M., Liu, Y., Regner, K.R., Jotterand, F., Liu, P., Liang, M.: Artificial intelligence, physiological genomics, and precision medicine. Physiol. Genom. 50(4), 237–243 (2018)CrossRef
10.
go back to reference Barker, R.W.: Is precision medicine the future of healthcare? Pers. Med. 14(6), 459–461 (2017)CrossRef Barker, R.W.: Is precision medicine the future of healthcare? Pers. Med. 14(6), 459–461 (2017)CrossRef
11.
go back to reference Bartlett, G., Rahimzadeh, V., Longo, C., Orlando, L.A., Dawes, M., Lachaine, J., Bochud, M., Paccaud, F., Bergman, H., Crimi, L., Issa, A.M.: The future of genomic testing in primary care: the changing face of personalized medicine. Pers. Med. 11, 477–486 (2014)CrossRef Bartlett, G., Rahimzadeh, V., Longo, C., Orlando, L.A., Dawes, M., Lachaine, J., Bochud, M., Paccaud, F., Bergman, H., Crimi, L., Issa, A.M.: The future of genomic testing in primary care: the changing face of personalized medicine. Pers. Med. 11, 477–486 (2014)CrossRef
13.
go back to reference Chang, L.-C., Colonna, T.E.: Recent updates and challenges on the regulation of precision medicine: the United States in perspective. Regul. Toxicol. Pharmacol. 96, 41–47 (2018)CrossRef Chang, L.-C., Colonna, T.E.: Recent updates and challenges on the regulation of precision medicine: the United States in perspective. Regul. Toxicol. Pharmacol. 96, 41–47 (2018)CrossRef
14.
go back to reference Conti, R., Veenstra, D.L., Armstrong, K., Lesko, L.J., Grosse, S.D.: Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med. Decis. Making 30(3), 328–340 (2010)CrossRef Conti, R., Veenstra, D.L., Armstrong, K., Lesko, L.J., Grosse, S.D.: Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. Med. Decis. Making 30(3), 328–340 (2010)CrossRef
15.
go back to reference Gray, M., Meehan, J., Ward, C., Langdon, S.P., Kunkler, I.H., Murray, A., Argyle, D.: Implantable biosensors and their contribution to the future of precision medicine. Vet. J. 239, 21–29 (2018)CrossRef Gray, M., Meehan, J., Ward, C., Langdon, S.P., Kunkler, I.H., Murray, A., Argyle, D.: Implantable biosensors and their contribution to the future of precision medicine. Vet. J. 239, 21–29 (2018)CrossRef
16.
go back to reference Malod-Dognin, N., Petschnigg, J., Pržulj, N.: Precision medicine - a promising, yet challenging road lies ahead. Curr. Opin. Syst. Biol. 7, 1–7 (2018)CrossRef Malod-Dognin, N., Petschnigg, J., Pržulj, N.: Precision medicine - a promising, yet challenging road lies ahead. Curr. Opin. Syst. Biol. 7, 1–7 (2018)CrossRef
17.
go back to reference Korngiebel, D.M., Thummel, K.E., Burke, W.: Implementing precision medicine: the ethical challenges. Trends Pharmacol. Sci. 38(1), 8–14 (2017)CrossRef Korngiebel, D.M., Thummel, K.E., Burke, W.: Implementing precision medicine: the ethical challenges. Trends Pharmacol. Sci. 38(1), 8–14 (2017)CrossRef
18.
go back to reference Love-Koh, J., Peel, A., Rejon-Parilla, J.C., Ennis, K., Lovett, R., Manca, A., Taylor, M.: The future of precision medicine: potential impacts for health technology assessment. PharmacoEconomics 36, 1439–1451 (2018)CrossRef Love-Koh, J., Peel, A., Rejon-Parilla, J.C., Ennis, K., Lovett, R., Manca, A., Taylor, M.: The future of precision medicine: potential impacts for health technology assessment. PharmacoEconomics 36, 1439–1451 (2018)CrossRef
Metadata
Title
Precision Medicine: A Personalized Treatment from Your Gene
Authors
P. K. Balasubramani
K. Preetha
M. Aswanth Harish
Copyright Year
2019
DOI
https://doi.org/10.1007/978-3-030-25135-2_2

Premium Partners